Copy Paste Quotes

Can a name change transform PCOS outcomes for women? – podcast

After more than a decade of global consultation, polycystic ovary syndrome – which affects as many as one in eight women – has been renamed. The condition is caused by high levels of androgens, which can lead to symptoms such as excess hair, weight gain and irregular periods. To understand why campaigners wanted it renamed, and what its new name – polyendocrine metabolic ovarian syndrome (PMOS) – could mean for patients, Madeleine Finlay hears from the Guardian’s science correspondent, Nicola Davis, and Rachel, a campaigner from the charity Verity

‘Unprecedented’ global effort leads to renaming of polycystic ovary syndrome – and fresh hope for millions of women

Support the Guardian: theguardian.com/sciencepod

Continue reading...

May 21, 2026 Polyendocrine metabolic ovarian syndrome (PMOS) Women's health Science

Need the full article?

Use the dedicated news page for the summary, then jump straight to the original source when you want the complete story.